aluates Reports

$ 0.0

Automative

Global Hospital Acquired Infections (HAI) Diagnostics Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-27S5820

Global Hospital Acquired Infections HAI Diagnostics Market Insights Forecast to 2028

BUY CHAPTERS

Global Hospital Acquired Infections (HAI) Diagnostics Market Insights, Forecast to 2029

Code: QYRE-Auto-27S5820

Report

August 2023

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hospital Acquired Infections (HAI) Diagnostics Market Size

The global Hospital Acquired Infections (HAI) Diagnostics market is projected to grow from US$ 3485.1 million in 2023 to US$ 4474.4 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.

Hospital Acquired Infections (HAI) Diagnostics Market

Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.

Market Analysis and Insights: Global Hospital Acquired Infections (HAI) Diagnostics Market

The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis.

Report Includes

This report presents an overview of global market for Hospital Acquired Infections (HAI) Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Hospital Acquired Infections (HAI) Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hospital Acquired Infections (HAI) Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hospital Acquired Infections (HAI) Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Hospital Acquired Infections (HAI) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Hospital Acquired Infections (HAI) Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BioMérieux, Abbott Laboratories, Roche AG and Siemens Healthcare, etc.

Scope of Hospital Acquired Infections (HAI) Diagnostics Market Report

Report Metric	Details
Report Name	Hospital Acquired Infections (HAI) Diagnostics Market
Accounted market size in 2023	US$ 3485.1 million
Forecasted market size in 2029	US$ 4474.4 million
CAGR	4.3
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Molecular Diagnostics Tests Other In-vitro Diagnostic Tests
Segment by Application	Bloodstream Infections (BSI) Urinary Tract Infections (UTI) Surgical Site Infections (SSI) Pneumonia Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioMérieux, Abbott Laboratories, Roche AG, Siemens Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hospital Acquired Infections (HAI) Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital Acquired Infections (HAI) Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hospital Acquired Infections (HAI) Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Hospital Acquired Infections (HAI) Diagnostics Market growing?

Ans: The Hospital Acquired Infections (HAI) Diagnostics Market witnessing a CAGR of 4.3 during the forecast period 2023-2029.

What is the Hospital Acquired Infections (HAI) Diagnostics Market size in 2029?

Ans: The global Hospital Acquired Infections (HAI) Diagnostics market is projected to grow from US$ 3485.1 million in 2023 to US$ 4474.4 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Molecular Diagnostics Tests

1.2.3 Other In-vitro Diagnostic Tests

1.3 Market by Application

1.3.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Bloodstream Infections (BSI)

1.3.3 Urinary Tract Infections (UTI)

1.3.4 Surgical Site Infections (SSI)

1.3.5 Pneumonia

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Perspective (2018-2029)

2.2 Global Hospital Acquired Infections (HAI) Diagnostics Growth Trends by Region

2.2.1 Hospital Acquired Infections (HAI) Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Region (2018-2023)

2.2.3 Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Region (2024-2029)

2.3 Hospital Acquired Infections (HAI) Diagnostics Market Dynamics

2.3.1 Hospital Acquired Infections (HAI) Diagnostics Industry Trends

2.3.2 Hospital Acquired Infections (HAI) Diagnostics Market Drivers

2.3.3 Hospital Acquired Infections (HAI) Diagnostics Market Challenges

2.3.4 Hospital Acquired Infections (HAI) Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Hospital Acquired Infections (HAI) Diagnostics by Players

3.1.1 Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Players (2018-2023)

3.1.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Players (2018-2023)

3.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio

3.4.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2022

3.5 Global Key Players of Hospital Acquired Infections (HAI) Diagnostics Head office and Area Served

3.6 Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Product and Application

3.7 Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Type

4.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Type (2018-2023)

4.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2024-2029)

5 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Application

5.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Application (2018-2023)

5.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2029)

6.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type

6.2.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023)

6.2.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029)

6.2.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

6.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application

6.3.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023)

6.3.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029)

6.3.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

6.4 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country

6.4.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)

6.4.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2029)

7.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type

7.2.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023)

7.2.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029)

7.2.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application

7.3.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023)

7.3.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029)

7.3.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

7.4 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country

7.4.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)

7.4.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2029)

8.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type

8.2.1 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023)

8.2.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029)

8.2.3 China Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

8.3 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application

8.3.1 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023)

8.3.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029)

8.3.3 China Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2029)

9.2 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type

9.2.1 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023)

9.2.2 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029)

9.2.3 Asia Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

9.3 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application

9.3.1 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023)

9.3.2 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029)

9.3.3 Asia Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

9.4 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Region

9.4.1 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2018-2023)

9.4.3 Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 BioMérieux

11.1.1 BioMérieux Company Details

11.1.2 BioMérieux Business Overview

11.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Introduction

11.1.4 BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

11.1.5 BioMérieux Recent Developments

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Introduction

11.2.4 Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

11.2.5 Abbott Laboratories Recent Developments

11.3 Roche AG

11.3.1 Roche AG Company Details

11.3.2 Roche AG Business Overview

11.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Introduction

11.3.4 Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

11.3.5 Roche AG Recent Developments

11.4 Siemens Healthcare

11.4.1 Siemens Healthcare Company Details

11.4.2 Siemens Healthcare Business Overview

11.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Introduction

11.4.4 Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

11.4.5 Siemens Healthcare Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Molecular Diagnostics Tests

Table 3. Key Players of Other In-vitro Diagnostic Tests

Table 4. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2018-2023)

Table 8. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2024-2029)

Table 10. Hospital Acquired Infections (HAI) Diagnostics Market Trends

Table 11. Hospital Acquired Infections (HAI) Diagnostics Market Drivers

Table 12. Hospital Acquired Infections (HAI) Diagnostics Market Challenges

Table 13. Hospital Acquired Infections (HAI) Diagnostics Market Restraints

Table 14. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Players (2018-2023)

Table 16. Global Top Hospital Acquired Infections (HAI) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2022)

Table 17. Global Hospital Acquired Infections (HAI) Diagnostics Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Headquarters and Area Served

Table 20. Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Product and Application

Table 21. Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type (2018-2023)

Table 25. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type (2024-2029)

Table 27. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Application (2018-2023)

Table 29. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Application (2024-2029)

Table 31. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Hospital Acquired Infections (HAI) Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Hospital Acquired Infections (HAI) Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Hospital Acquired Infections (HAI) Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2024-2029) & (US$ Million)

Table 63. BioMérieux Company Details

Table 64. BioMérieux Business Overview

Table 65. BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product

Table 66. BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023) & (US$ Million)

Table 67. BioMérieux Recent Developments

Table 68. Abbott Laboratories Company Details

Table 69. Abbott Laboratories Business Overview

Table 70. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product

Table 71. Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023) & (US$ Million)

Table 72. Abbott Laboratories Recent Developments

Table 73. Roche AG Company Details

Table 74. Roche AG Business Overview

Table 75. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product

Table 76. Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023) & (US$ Million)

Table 77. Roche AG Recent Developments

Table 78. Siemens Healthcare Company Details

Table 79. Siemens Healthcare Business Overview

Table 80. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product

Table 81. Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023) & (US$ Million)

Table 82. Siemens Healthcare Recent Developments

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Type: 2022 VS 2029

Figure 3. Molecular Diagnostics Tests Features

Figure 4. Other In-vitro Diagnostic Tests Features

Figure 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application: 2022 VS 2029

Figure 7. Bloodstream Infections (BSI) Case Studies

Figure 8. Urinary Tract Infections (UTI) Case Studies

Figure 9. Surgical Site Infections (SSI) Case Studies

Figure 10. Pneumonia Case Studies

Figure 11. Others Case Studies

Figure 12. Hospital Acquired Infections (HAI) Diagnostics Report Years Considered

Figure 13. Global Hospital Acquired Infections (HAI) Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Hospital Acquired Infections (HAI) Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region: 2022 VS 2029

Figure 16. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Players in 2022

Figure 17. Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2022

Figure 19. North America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

Figure 21. North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

Figure 22. North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2018-2029)

Figure 23. United States Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Canada Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 26. Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

Figure 27. Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

Figure 28. Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2018-2029)

Figure 29. Germany Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. France Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. U.K. Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Italy Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Russia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. China Hospital Acquired Infections (HAI) Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 36. China Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

Figure 37. China Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

Figure 38. Asia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 39. Asia Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

Figure 40. Asia Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

Figure 41. Asia Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2018-2029)

Figure 42. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. China Taiwan Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. India Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Australia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Share by Type (2018-2029)

Figure 50. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Share by Application (2018-2029)

Figure 51. Middle East, Africa, and Latin America Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2018-2029)

Figure 52. Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Israel Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. GCC Countries Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. BioMérieux Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

Figure 59. Abbott Laboratories Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

Figure 60. Roche AG Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

Figure 61. Siemens Healthcare Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2018-2023)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions